Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication
Open Access
- 8 February 2022
- journal article
- review article
- Published by Taylor & Francis in Virulence
- Vol. 13 (1) , 323-340
Abstract
Human pegivirus (HPgV-1), previously known as GB virus C (GBV-C) or hepatitis G virus (HGV), is a single-stranded positive RNA virus belonging to the genus Pegivirus of the Flaviviridae family. It is transmitted by percutaneous injuries (PIs), contaminated blood and/or blood products, sexual contact, and vertical mother-to-child transmission. It is widely prevalent in general population, especially in high-risk groups. HPgV-1 viremia is typically cleared within the first 1–2 years of infection in most healthy individuals, but may persist for longer periods of time in immunocompromised individuals and/or those co-infected by other viruses. A large body of evidences indicate that HPgV-1 persistent infection has a beneficial clinical effect on many infectious diseases, such as acquired immunodeficiency syndrome (AIDS) and hepatitis C. The beneficial effects seem to be related to a significant reduction of immune activation, and/or the inhabitation of co-infected viruses (e.g. HIV-1). HPgV-1 has a broad cellular tropism for lymphoid and myeloid cells, and preferentially replicates in bone marrow and spleen without cytopathic effect, implying a therapeutic potential. The paper aims to summarize the natural history, prevalence and distribution characteristics, and pathogenesis of HPgV-1, and discuss its association with other human viral diseases, and potential use in therapy as a biovaccine or viral vector.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 260 references indexed in Scilit:
- Identification of Rodent Homologs of Hepatitis C Virus and PegivirusesmBio, 2013
- Bats are a major natural reservoir for hepaciviruses and pegivirusesProceedings of the National Academy of Sciences, 2013
- Hepatitis C virus: virology and life cycleClinical and Molecular Hepatology, 2013
- GB virus C: the good boy virus?Trends in Microbiology, 2012
- Peptides Derived from a Distinct Region of GB Virus C Glycoprotein E2 Mediate Strain-Specific HIV-1 Entry InhibitionJournal of Virology, 2011
- Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in GermanyJournal of Medical Virology, 2011
- The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family FlaviviridaeJournal of General Virology, 2010
- The natural history of non-human GB virus C in captive chimpanzeesJournal of General Virology, 2010
- GB virus type C interactions with HIV: the role of envelope glycoproteinsJournal of Viral Hepatitis, 2009
- Structural biology of hepatitis C virusHepatology, 2004